G Scambia

No ORCID on file · 33 papers in corpus
case-report 2005
Gynecologic Oncology ·doi:10.1016/j.ygyno.2005.06.056

BACKGROUND: Malignant transformation may occur in up to 1% of women with endometriosis and only 20% of these cases occur at extragonadal pelvic sites. Similarly, urinary tract endometriosis is rare and occurs in only 1% of all endometriotic…

case-report 2004
Ultrasound in Obstetrics & Gynecology ·doi:10.1002/uog.1736

The discovery of an ovarian mass during pregnancy is often a difficult issue because of the risk related to surgical intervention during pregnancy. Moreover, ultrasound examination is often unable to provide a definitive diagnosis. A case o…

case-report 1999
Journal of neurology, neurosurgery, and psychiatry ·doi:10.1136/jnnp.67.3.412
rct 1993
Gynecologic Oncology ·doi:10.1006/gyno.1993.1197

To compare two different surgical techniques for the resection of the cardinal ligaments during radical operation for cervical cancer, 84 patients with locally advanced cervical cancer (FIGO stages IB-IIA > or = 4 cm, IIB-III) primarily tre…

other 1990
Oncology ·doi:10.1159/000226836

Fourteen patients with advanced ovarian carcinoma (FIGO stages III-IV) resistant to cisplatin were submitted to an alternating regimen with doxorubicin (A), cyclophosphamide (C), bleomycin (B) and mitomycin C (M). All patients had measurabl…

diagnostic-accuracy 1990
European journal of gynaecological oncology

Between March 1986 and March 1989, 65 epithelial ovarian carcinomas were studied by means of real time high resolution ultrasound. The sonographic findings were correlated with FIGO stage, histotype and histological grade. The echostructure…

other 1988
Gynecologic Oncology ·doi:10.1016/0090-8258(88)90032-7

Serum levels of CA 15-3 were measured in 778 samples from 270 patients with benign and malignant gynecological conditions. Malignant tumors were present in 180 patients including 58 cases with cancer of the ovary, 47 of the endometrium, 61 …

other 1988
Anticancer research

Serum levels of CA125 and 90K, a new tumor-associated antigen, were measured in 73 ovarian cancer patients and 70 patients with benign gynecological conditions. Abnormally high serum CA 125 and 90K levels were found in 49% and 78% of these …